Advertisement
BMRN vs EYE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a StrongBuy and EYE is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BMRN’s FA Score shows that 0 FA rating(s) are green whileEYE’s FA Score has 1 green FA rating(s).
- BMRN’s FA Score: 0 green, 5 red.
- EYE’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BMRN’s TA Score shows that 4 TA indicator(s) are bullish while EYE’s TA Score has 3 bullish TA indicator(s).
- BMRN’s TA Score: 4 bullish, 6 bearish.
- EYE’s TA Score: 3 bullish, 4 bearish.
Price Growth
BMRN (@Biotechnology) experienced а -3.20% price change this week, while EYE (@Specialty Stores) price change was -3.24% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +16.82%, and the average quarterly price growth was +37.20%.
The average weekly price growth across all stocks in the @Specialty Stores industry was -6.30%. For the same industry, the average monthly price growth was -5.15%, and the average quarterly price growth was +0.36%.
Reported Earning Dates
BMRN is expected to report earnings on Oct 22, 2025.
EYE is expected to report earnings on Nov 06, 2025.
Industries' Descriptions
@Biotechnology (+1.32% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Specialty Stores (-6.30% weekly)The specialty stores sector includes companies dedicated to the sale of retail products focused on a single product category, such as clothing, carpet, books, or office supplies. A specialty store could face intense competition from big-box departmental chains, and therefore offering an adequate collection of the product type it specializes in is key in maintaining/growing its market.
| BMRN | EYE | BMRN / EYE | |
| Capitalization | 11.2B | 1.74B | 646% |
| EBITDA | 777M | 54M | 1,439% |
| Gain YTD | -11.547 | 132.342 | -9% |
| P/E Ratio | 21.43 | 51.02 | 42% |
| Revenue | 2.95B | 2.13B | 139% |
| Total Cash | 1.27B | 150M | 848% |
| Total Debt | 602M | 923M | 65% |
BMRN | EYE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 12 | 71 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 61 Fair valued | 60 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 69 | 90 | |
PRICE GROWTH RATING 1..100 | 61 | 36 | |
P/E GROWTH RATING 1..100 | 98 | 18 | |
SEASONALITY SCORE 1..100 | n/a | 29 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EYE's Valuation (60) in the Specialty Stores industry is in the same range as BMRN (61) in the Biotechnology industry. This means that EYE’s stock grew similarly to BMRN’s over the last 12 months.
EYE's Profit vs Risk Rating (100) in the Specialty Stores industry is in the same range as BMRN (100) in the Biotechnology industry. This means that EYE’s stock grew similarly to BMRN’s over the last 12 months.
BMRN's SMR Rating (69) in the Biotechnology industry is in the same range as EYE (90) in the Specialty Stores industry. This means that BMRN’s stock grew similarly to EYE’s over the last 12 months.
EYE's Price Growth Rating (36) in the Specialty Stores industry is in the same range as BMRN (61) in the Biotechnology industry. This means that EYE’s stock grew similarly to BMRN’s over the last 12 months.
EYE's P/E Growth Rating (18) in the Specialty Stores industry is significantly better than the same rating for BMRN (98) in the Biotechnology industry. This means that EYE’s stock grew significantly faster than BMRN’s over the last 12 months.
| BMRN | EYE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 69% | 2 days ago 75% |
| Stochastic ODDS (%) | 2 days ago 72% | 2 days ago 81% |
| Momentum ODDS (%) | 2 days ago 73% | 2 days ago 75% |
| MACD ODDS (%) | 2 days ago 74% | N/A |
| TrendWeek ODDS (%) | 2 days ago 65% | 2 days ago 71% |
| TrendMonth ODDS (%) | 2 days ago 52% | 2 days ago 78% |
| Advances ODDS (%) | 3 days ago 59% | 17 days ago 76% |
| Declines ODDS (%) | 5 days ago 62% | 2 days ago 69% |
| BollingerBands ODDS (%) | 2 days ago 77% | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 47% | 2 days ago 76% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BSCW | 20.74 | 0.17 | +0.83% |
| Invesco BulletShares 2032 Corp Bd ETF | |||
| CADCHF | 0.59 | 0.00 | N/A |
| Canadian Dollar - Switzerland Franc | |||
| CNYAUD | 0.22 | -0.00 | -0.05% |
| China Yuan - Australian Dollar | |||
| XISE | 30.22 | -0.05 | -0.17% |
| FT Vest US Eq Buf & Prm IncETF-Sept | |||
| XRT | 77.85 | -0.61 | -0.78% |
| SPDR® S&P Retail ETF | |||
BMRN and
Correlation & Price change
A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with ITOS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then ITOS could also see price increases.
| Ticker / NAME | Correlation To BMRN | 1D Price Change % | ||
|---|---|---|---|---|
| BMRN | 100% | +0.50% | ||
| ITOS - BMRN | 50% Loosely correlated | -0.49% | ||
| SRPT - BMRN | 45% Loosely correlated | -3.11% | ||
| IONS - BMRN | 43% Loosely correlated | +0.12% | ||
| AXON - BMRN | 42% Loosely correlated | -1.72% | ||
| IBO - BMRN | 42% Loosely correlated | +0.57% | ||
More | ||||